A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects

Clinical trial NCT01803412 · TERMINATED

Trial details

NCT number: NCT01803412
Sponsor: BioMarin Pharmaceutical
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophies

Start date: 2013-05-01
Primary completion: 2016-06-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.